COMT and Anxiety: Particular evidence is accumulating for the catechol-O-methyltransferase (COMT) as a promising candidate gene in the pathogenesis of anxiety and affective disorders: COMT catalyzes the inactivation of monoaminergic neurotransmitters, particularly dopamine and norepinephrine, by an extraneural transfer of a methyl group to catechol compounds.